Identifying patients with significant hypoalbuminemia on admission could prompt early interventions, such as nutritional optimization, enhanced monitoring, and proactive management of comorbidities to potentially mitigate adverse outcomes. Albumin not only reflects nutritional status [18] but also correlates inversely with systemic inflammation and comorbidity burden [3], reinforcing its value as a multidimensional biomarker. Here, ALB is linked to Hypoalbuminemia.